IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis.
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
    Wosiski-Kuhn M, Robinson M, Strupe J, Arounleut P, Martin M, Caress J, Cartwright M, Bowser R, Cudkowicz M, Langefeld C, Hawkins GA, Milligan C. IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2019 11; 6(6):e631.